NeOnc科技控股公司GAAP每股收益为0.30美元

2025-08-20 03:35

NeOnc Technologies Holdings press release (NASDAQ:NTHI): Q2 GAAP EPS of $0.30.
G&A expenses: $984K vs. $290K in Q2 2024, reflecting expanded marketing, rent, travel, and Middle East partnership-related costs.
R&D expenses: $677K vs. $394K in Q2 2024, driven by additional NEO100 trial sites, increased recruitment for NEO212, initiation of NEO100-3, and overall patient recruitment expansion.

More on NeOnc Technologies Holdings